Aurora Cannabis Inc. (ACB) Estados Financieros e Histórico

Aurora Cannabis Inc. (ACB) — Precio $3.83 HealthcareDrug Manufacturers - Specialty & Generic — NASDAQ

Últimos resultados publicados:

Estados financieros detallados de Aurora Cannabis Inc. (ACB): cuenta de resultados, balance general y flujo de caja. Sigue la evolución de márgenes, deuda, liquidez y rentabilidad año a año con hasta 20 años de histórico.

Resumen del Análisis

Aurora Cannabis Inc. registró ingresos de $320.6M en el último ejercicio fiscal, con un CAGR de 5 años del 5.5%.

Márgenes de los últimos 12 meses: margen bruto 32.1%, margen operativo -29.7%, margen neto -38.2%.

Al precio actual de $3.83, ACB presenta beneficios negativos (P/E no significativo) y un ROE del -21.00%. La capitalización bursátil es de $237M.

Cuenta de Resultados (10 años)

Año2017201820192020202120222023202420252026
Ingresos$18.1M$55.2M$245.5M$268.7M$245.3M$221.3M$223.8M$270.3M$343.3M$320.6M
Coste de Ventas$2.0M$11.7M$103.1M$288.6M$266.8M$200.1M$209.0M$138.8M$155.7M$183.9M
Beneficio Bruto$16.1M$43.5M$142.4M-$19.9M-$21.6M$21.2M$14.8M$131.5M$187.6M$136.7M
I+D$314000$1.7M$14.8M$26.0M$11.4M$10.4M$5.8M$3.6M$3.7M$4.0M
Generales y Administrativos$24.7M$109.9M$365.4M$345.8M$194.9M$189.0M$170.5M$156.9M$166.5M$166.2M
Gastos Operativos$27.2M$139.3M$460.7M$445.8M$261.3M$252.7M$222.0M$177.9M$182.7M$183.3M
Beneficio Operativo-$11.2M-$95.8M-$318.3M-$465.8M-$282.8M-$231.4M-$207.2M-$46.5M$4.9M-$46.7M
EBITDA-$14.9M$101.3M-$203.0M-$3.15B-$535.3M-$1.55B-$135.0M-$12.3M$51.3M-$50.9M
Gastos por Intereses$1.3M$11.8M$39.4M$76.1M$66.4M$71.8M$39.5M$14.2M$8.4M$1.8M
Beneficio Antes de Impuestos-$17.3M$77.3M-$330.6M-$3.34B-$699.8M-$1.72B-$783.7M-$59.6M$20.4M-$56.5M
Impuestos-$4.3M$8.1M-$29.9M-$82.2M-$6.3M-$2.1M$16.5M-$554000$4.6M$2.1M
Beneficio Neto-$13.0M$71.9M-$293.5M-$3.28B-$693.6M-$1.74B-$816.6M-$69.3M$1.6M-$121.8M
BPA$-5.58$18.00$-36.65$-333.92$-40.92$-79.92$-8.17$-1.28$0.03$-2.15
BPA Diluido$-6.00$18.00$-36.65$-333.92$-40.92$-79.92$-8.17$-1.28$0.03$-2.14
Acciones en Circulación (Diluidas)$2.3M$3.9M$8.0M$9.7M$16.9M$21.5M$32.3M$51.3M$55.8M$57.3M

Cuenta de Resultados (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Ingresos$90.4M$94.2M$38.1M$67.6M
Beneficio Bruto$32.3M$46.6M$18.2M-$4.0M
Beneficio Operativo-$18.3M$4.8M-$25.2M-$47.5M
EBITDA-$38.5M$8.6M$6.4M-$43.5M
Beneficio Neto-$51.5M$1.8M-$57.0M-$4.0M
BPA$-0.91$0.03$-0.99$-0.07
BPA Diluido$-0.91$0.03$-0.99$-0.07

Balance (10 años)

Año2017201820192020202120222023202420252026
Caja y Equivalentes$160.3M$90.8M$219.6M$161.5M$440.3M$300.9M$300.9M$179.5M$184.3M$112.8M
Inversiones a Corto$15.0M$59.6M$143.8M$7.0M$3.7M00$4.0M$550815$52.3M
Cuentas por Cobrar$2.3M$15.2M$112.8M$53.9M$56.2M$41.3M$41.3M$45.5M$42.2M$44.7M
Inventario$11.8M$43.5M$162.5M$153.4M$137.5M$128.8M$128.8M$186.7M$237.7M$175.5M
Activos Corrientes$194.3M$221.2M$663.1M$415.8M$665.1M$480.0M$480.0M$427.3M$475.6M$398.5M
Inmovilizado Material$45.7M$248.0M$768.5M$942.4M$605.3M$323.0M$323.0M$294.8M$266.6M$124.0M
Fondo de Comercio$41.2M$766.0M$3.18B$924.0M$886.6M$18.7M$18.7M$43.3M$43.6M$26.7M
Activos Intangibles$31.2M$201.7M$691.0M$410.5M$367.0M$59.7M$59.7M$40.9M$44.9M$31.5M
Activos Totales$323.8M$1.90B$5.64B$2.92B$2.72B$926.4M$926.4M$840.1M$847.8M$602.6M
Cuentas por Pagar$8.8M$47.8M$38.8M$19.6M$13.3M$21.9M$21.9M$20.4M$27.5M$9.3M
Deuda a Corto$69244$2.5M$250.6M$152.0M$40.9M$147.6M$147.6M$57.3M$26.7M$5.7M
Pasivos Corrientes$23.5M$75.7M$438.0M$271.1M$116.2M$237.8M$237.8M$124.8M$110.2M$67.1M
Deuda a Largo$63.8M$202.1M$396.7M$293.7M$292.8M$36.2M$36.2M$4.9M$40.0M0
Pasivos Totales$104.1M$335.9M$1.23B$802.6M$686.0M$404.6M$404.6M$237.2M$242.7M$89.5M
Reservas-$28.5M$88.4M-$287.4M-$3.58B-$4.32B-$6.29B-$6.29B-$6.38B-$6.33B-$6.46B
Patrimonio Neto$219.7M$1.56B$4.40B$2.14B$2.04B$490.7M$490.7M$560.7M$563.9M$513.2M
Deuda Total$64.1M$204.6M$647.3M$529.0M$399.0M$226.4M$226.4M$99.8M$104.0M$23.9M
Deuda Neta-$111.1M$54.2M$283.9M$360.5M-$45.0M-$74.5M-$74.5M-$83.8M-$80.8M-$141.2M
Capital Circulante$170.7M$145.5M$225.1M$144.6M$548.8M$242.2M$242.2M$302.5M$365.4M$331.4M

Balance (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Caja y Equivalentes$95.7M$56.4M$112.8M$118.4M
Activos Totales$756.9M$775.3M$602.6M$621.1M
Pasivos Totales$189.8M$207.5M$89.5M$93.8M
Patrimonio Neto$531.9M$536.4M$513.2M$527.4M
Deuda Total$100.3M$101.0M$23.9M$22.7M

Flujo de Caja (10 años)

Año2017201820192020202120222023202420252026
Beneficio Neto-$13.0M$69.2M-$300.7M-$3.26B-$693.5M-$1.72B-$173.4M-$57.1M$15.8M-$58.6M
Amortizaciones$1.1M$12.3M$88.3M$114.7M$98.1M$93.7M$31.2M$32.8M$22.5M$14.2M
Compensación en Acciones$7.6M$37.5M$107.0M$59.2M$20.2M$13.8M$16.9M$12.7M$11.5M$7.3M
Cambio en Capital Circulante-$2.5M-$25.4M-$37.3M$7.6M$397000$52.7M-$18.4M-$15.5M$10.2M-$9.2M
Flujo de Caja Operativo-$13.4M-$81.7M-$192.2M-$342.1M-$210.6M-$110.3M-$85.6M-$68.5M$16.0M-$13.5M
Inversiones (CapEx)-$25.7M-$136.9M-$414.2M-$348.8M-$53.1M-$32.2M-$6.9M-$16.8M-$18.9M-$22.5M
Adquisiciones-$6.9M-$335.6M$114.3M$27.9M0-$23.4M-$13.7M-$5.5M00
Recompra de Acciones0000000000
Dividendos Pagados0000000000
Flujo de Caja Libre-$39.1M-$218.6M-$606.4M-$691.0M-$263.7M-$142.5M-$92.5M-$85.3M-$2.9M-$36.1M

Flujo de Caja (Trimestral)

Año2025-Q32025-Q42026-Q12026-Q2
Flujo de Caja Operativo-$40.4M$17.0M-$230000-$4.4M
Inversiones (CapEx)-$6.3M-$6.0M-$5.2M-$5.4M
Flujo de Caja Libre-$46.7M$11.0M-$5.4M-$9.9M
Dividendos Pagados0000
Compensación en Acciones$5.0M-$551000$689000$693000

Crecimiento y Márgenes (10 años)

Año2017201820192020202120222023202420252026
Crecimiento Ingresos (anual)+205.5%+344.8%+9.4%-8.7%-9.8%+1.1%+20.8%+27.0%-6.6%
Crecimiento Beneficio Neto (anual)+654.7%-508.0%-1018.4%+78.9%-150.7%+53.0%+91.5%+102.3%-7753.0%
Crecimiento BPA (anual)+422.6%-303.6%-811.1%+87.7%-95.3%+89.8%+84.3%+102.3%-7513.8%
Cambio en Acciones (anual)+68.9%+104.0%+20.8%+74.8%+27.1%+50.2%+58.8%+8.8%+2.8%
Crecimiento FCF (anual)-459.2%-177.4%-13.9%+61.8%+46.0%+35.1%+7.8%+96.7%-1163.3%
Margen Bruto88.9%78.8%58.0%-7.4%-8.8%9.6%6.6%48.6%54.6%42.6%
Margen Operativo-61.9%-173.5%-129.6%-173.3%-115.3%-104.6%-92.6%-17.2%1.4%-14.6%
Margen EBITDA-82.4%183.6%-82.7%-1171.9%-218.3%-702.4%-60.3%-4.6%15.0%-15.9%
Margen Neto-71.8%130.3%-119.5%-1221.7%-282.8%-785.8%-364.9%-25.6%0.5%-38.0%
Margen FCF-216.4%-396.1%-247.0%-257.1%-107.5%-64.4%-41.3%-31.6%-0.8%-11.2%
Tasa Impositiva Efectiva24.9%10.5%9.0%2.5%0.9%0.1%-2.1%0.9%22.7%-3.7%

Datos por Acción (10 años)

Año2017201820192020202120222023202420252026
FCF por Acción$-16.81$-55.66$-75.69$-71.41$-15.59$-6.63$-2.87$-1.66$-0.05$-0.63
Dividendo por Acción$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00$0.00
Acciones en Circulación (Básicas)$2.2M$3.9M$8.0M$9.7M$16.9M$21.5M$32.3M$51.3M$54.9M$56.7M

Qué mirar en Salud / Farma

El pipeline de I+D es el activo invisible. Patentes que caducan = ingresos que evaporan. Mira innovación y flujo de caja.

Rentabilidad

Rentabilidad sobre capital-21.00%
Rentabilidad sobre capital invertido-15.55%
Rentabilidad sobre activos-17.83%
Margen bruto32.08%
Margen operativo-29.66%
Margen neto-38.15%

Salud financiera

Deuda / Patrimonio0.04
Ratio corriente5.36

Ratios Clave (10 años)

Año2017201820192020202120222023202420252026
P/E-46.5261.97-33.56-0.50-2.74-0.21-1.15-4.55217.78-2.12
P/VC2.552.812.240.760.930.740.620.530.610.50
P/V31.0679.3840.126.077.731.651.361.111.010.80
Margen Bruto88.9%78.8%58.0%-7.4%-8.8%9.6%6.6%48.6%54.6%42.6%
Margen Operativo-61.9%-173.5%-129.6%-173.3%-115.3%-104.6%-92.6%-17.2%1.4%-14.6%
Margen Neto-71.8%130.3%-119.5%-1221.7%-282.8%-785.8%-364.9%-25.6%0.5%-38.0%

Empresas relacionadas: ACRS · BIOA · CGC · EDIT · HITI · IRWD · LFCR

Explorar sector: Healthcare · Drug Manufacturers - Specialty & Generic

Más secciones de ACB: Resumen · Valoración · Estadísticas · Estimaciones · Técnico · Propiedad · Noticias · Eventos

Descubre más: Radar — señales de acciones infravaloradas · Academia de Inversión — aprende a analizar acciones